The UK Government has proposed changes to the procurement regime for public sector contracts in the UK. The proposals mark a radical divergence from the European procurement regimes post Brexit. The proposals are set out in a...more
On February 19 2021, the European Union Commission issued its draft adequacy decision for data flows between the European Union (EU) and United Kingdom (UK).
Whilst widely expected, this draft decision will provide some...more
On February 11, 2021 the UK Department of Health and Social Care published its White Paper setting out legislative proposals for a Health and Care Bill. The White Paper proposes wide changes to the structure of the NHS in...more
In light of the COVID-19 pandemic, our 9th McDermott International Seminar Series will be held as a virtual series, with eight sessions taking place between January 21 – February 4, 2021. Though we cannot see you in person,...more
1/7/2021
/ Acquisitions ,
Biden Administration ,
Compliance ,
Coronavirus/COVID-19 ,
Cross-Border Transactions ,
Cybersecurity ,
Data Privacy ,
Enforcement Actions ,
FRAND ,
Global Market ,
Intellectual Property Protection ,
International Data Transfers ,
Investors ,
Japan ,
Mergers ,
Patent Portfolios ,
US Trade Policies ,
Webinars ,
White Collar Crimes
McDermott was delighted to partner with the BVCA (British Venture Capital Association) on its recent virtual Sector Forum Series: Healthcare event. The event gathered industry experts – from entrepreneurs, to investors and...more
12/3/2020
/ Capital Markets ,
Digital Health ,
Entrepreneurs ,
EU ,
Healthcare ,
Investment ,
Investment Adviser ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Private Equity ,
UK ,
Venture Capital
The combination of the Coronavirus (COVID-19) pandemic and the imminent end of the Brexit transition period means a fast-changing regulatory environment for medicines.
On 16 October 2020, the UK Government made changes to...more
10/28/2020
/ Applications ,
Clinical Trials ,
Coronavirus/COVID-19 ,
Exports ,
Imports ,
Licenses ,
Medical Devices ,
Medicines and Healthcare Products Regulatory Agency (MHRA) ,
New Regulations ,
UK ,
UK Brexit
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has published guidance on the new rules that will govern the regulation of medical devices and in vitro diagnostic medical devices placed on the market in...more
In light of the COVID-19 pandemic, the third annual European Healthcare Private Equity Symposium will be conducted as a five-part webinar series, taking place over five weeks in a virtual tour across several European...more
6/30/2020
/ Coronavirus/COVID-19 ,
Digital Health ,
Health Care Providers ,
Health Technology ,
Industry Consolidation ,
Innovation ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Webinars
The Legal Impact in Europe on Pharmaceutical and Medical Device Companies -
The current crisis mode has triggered legal and commercial issues that affect the pharmaceutical and medical device industry across...more
5/27/2020
/ Coronavirus/COVID-19 ,
Cybersecurity ,
Data Protection ,
EU ,
European Commission ,
European Competition Network (ECN) ,
Exports ,
Force Majeure Clause ,
Homeland Security Cybersecurity & Infrastructure Security Agency (CISA) ,
Imports ,
Intellectual Property Protection ,
Manufacturers ,
Medical Devices ,
Pharmaceutical Industry ,
Remote Working ,
UK ,
Wine & Alcohol
Across the US and EU, life sciences companies are pushing diagnostics, antibody testing, vaccines and other efforts forward to flatten the Coronavirus (COVID-19) curve. Our multidisciplinary cross-border life sciences team...more
5/5/2020
/ Acquisitions ,
Contact Tracing ,
Coronavirus/COVID-19 ,
Cross-Border Transactions ,
Diagnostic Tests ,
Digital Health ,
Divestiture ,
Due Diligence ,
Foreign Investment ,
Health Care Providers ,
Intellectual Property Protection ,
Joint Venture ,
Life Sciences ,
Medical Testing ,
Mergers ,
Partnerships ,
Pharmaceutical Industry ,
Regulatory Oversight ,
Vaccinations ,
Virus Testing ,
Webinars
The impact of Coronavirus (COVID-19) on pharmaceutical and medical device companies has been unique as, not only have these businesses had to set up emergency management systems practically overnight in order to maintain...more
4/2/2020
/ Clinical Trials ,
Coronavirus/COVID-19 ,
Emergency Management Plans ,
Export Bans ,
Medical Devices ,
Personal Protective Equipment ,
Pharmaceutical Industry ,
State of Emergency ,
Supply Chain ,
UK ,
UK Brexit
The UK government has introduced sweeping changes to the UK health legislation as it urgently prepares for the impact of the Coronavirus (COVID-19) pandemic, including increased admissions and demand for intensive care...more
4/1/2020
/ Affiliated-Business Arrangements ,
Business Interruption ,
Coronavirus/COVID-19 ,
Financial Stimulus ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
Medical Devices ,
Medical Supplies ,
Relief Measures ,
Small Business ,
Tax Relief
From the rise of digital health opportunities to concerns stemming from political shifts, McDermott partners review major European health trends in 2019 and look forward to what we might expect to see from 2020 onwards....more
McDermott Will & Emery is delighted to welcome you to a panel discussion on “Private Equity in Healthcare” and a social reception held in conjunction with the SuperReturn International Conference 2020.
Our speakers will...more
2/11/2020
/ Events ,
Foreign Investment ,
Health Care Providers ,
Hospitals ,
Investment Funds ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Physicians ,
Private Equity
The United Kingdom is no longer a member of the European Union and has entered into a transition period until December 31 2020, unless an extension of 1 or 2 years is agreed by July 1 2020 (the Brexit Long Stop...more
A recent McDermott round table on European health private equity generated key insights into the future of medtech, digital health, and data analytics, and identified opportunities for companies and investors.
Digital...more
12/20/2019
/ CFIUS ,
Digital Health ,
Digital Services Tax ,
Global Dealmaking ,
Healthcare ,
International Arbitration ,
Life Sciences ,
Medical Devices ,
Outbound Transactions ,
Private Equity ,
State-Owned Enterprises ,
UK Competition and Markets Authority (CMA)
The MDR and other recent developments in the health care regulatory landscape pose new opportunities and challenges for medical software companies and investors in digital health in the United Kingdom. Although the regulatory...more
7/3/2019
/ Biotechnology ,
Certification Requirements ,
Code of Conduct ,
Digital Health ,
EU ,
Innovation ,
Life Sciences ,
Manufacturers ,
Medical Devices ,
Member State ,
New Regulations ,
No-Deal Brexit ,
Regulatory Oversight ,
UK
SPECIAL REPORT -
BREXIT: CHALLENGES AND OPPORTUNITIES -
In this report, we explain some of the key legal implications associated with the United Kingdom leaving the European Union (EU) without a deal for future...more
3/25/2019
/ Article 50 Treaty of the EU ,
Banking Sector ,
Court of Justice of the European Union (CJEU) ,
Data Protection ,
EU ,
European Securities and Markets Authority (ESMA) ,
Financial Institutions ,
General Data Protection Regulation (GDPR) ,
Hague Agreement ,
International Data Transfers ,
International Labor Laws ,
International Tax Issues ,
Pharmaceutical Industry ,
Supply Chain ,
UK ,
UK Brexit ,
Value-Added Tax (VAT) ,
Withdrawal Agreement ,
WTO
Introduction -
The past year was an active one for data privacy and security legislation and enforcement. Protection for certain personal data was enhanced internationally by the EU General Data Protection Regulation...more
1/29/2019
/ Biometric Information ,
Biometric Information Privacy Act ,
California Consumer Privacy Act (CCPA) ,
Cybersecurity ,
Data Protection ,
Digital Health ,
Electronic Protected Health Information (ePHI) ,
EU ,
General Data Protection Regulation (GDPR) ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Personally Identifiable Information ,
State Data Breach Notification Statutes ,
UK
Data Inspections in China: Increased Supervision and Compliance -
Data protection inspections have become more frequent for companies with operations in China. Many companies are struggling for guidance on how to...more
In September 2018, the UK government published an initial code of conduct for data-driven health and care technology.
Advancements in health technology, especially in artificial intelligence (AI), have been widely heralded...more
Investors will find little holiday cheer in the Competition & Markets Authority (CMA) final report on the UK Care Sector, published 30 November 2017.
The report focusses on consumer protections and the sector’s financial...more
Cross Border M&A: The Impact of Brexit, the Trump Administration, and China’s Crackdown on Capital Flight
The combination of Brexit, the Trump Administration, and China’s tightening grasp on capital, appear to have created...more
12/6/2017
/ Acquisitions ,
Bilateral Investment Treaties ,
Capital Markets ,
China ,
Cross-Border Transactions ,
Department of Justice (DOJ) ,
Dispute Resolution ,
EU Data Protection Laws ,
Federal Trade Commission (FTC) ,
Foreign Acquisitions ,
Foreign Investment ,
Health Care Providers ,
Insolvency ,
Mergers ,
NAFTA ,
Trump Administration ,
UK Brexit ,
UK Insolvency Act
For investors considering the UK care sector, the Care Quality Commission (CQC) State of Care report released 10 October 2017 again raises alarm bells. Beds in nursing homes declined meaningfully, and funding pressures are...more
Nationalism and Cross-Border M&A: Navigating Populist Politics in Deal Making -
More than half of the G20 countries voted-in campaigns that focused on harming foreign, outside interests as a means to strengthen domestic...more
9/5/2017
/ ACOs ,
Acquisitions ,
Arbitration ,
Arbitration Awards ,
Artificial Intelligence ,
China ,
Customer-Loyalty Programs ,
Data Breach ,
Data Controller ,
Data Privacy ,
Due Diligence ,
EU ,
General Data Protection Regulation (GDPR) ,
Health Care Providers ,
Hospitals ,
India ,
Joint Venture ,
Long-Term Investment Funds ,
Mergers ,
Personal Data ,
Shareholders ,
UK